◆ SpookStack

ba DAY 3: be b7c Chairmen: #7: Vaccines and immune responses Co-Chairmen: land B. Ivins AVA and rPA vaccine potency and safety: comparisons in animals (Ivins or[—] Efficacy of AVA against vaccine-refractory strains r Ivins) . DNA vaccin, “ (eg. ER) (or- etal.) ‘ PA-proslicing recombinant B.anthracis vaccines LF-fusion erste Other experimental vaccines: (Live attenuated recombinant vaccine[ Cid Correlates of immune protection (possible subjects . . ) In vitro correlate/animal models USAMRIID pena ced] Human immune responses to anthrax vaccine {] The SCID mouse model- #8: Prevention and Treatment [Or Human Vaccines and Treatments] Chairmen: Anthrax vaccination: Safety and immunogenicity of alternate schedules and routes: A Senvetince-otigy personnel immunized with AVA: Human Clinical studies with PAVAX Alternate: Combine categories #7 and #8: iment Treatment Human antitoxin antibodies ("scFV": CS Tos Alamos) Toxin competitive inhibitors pas2"[ Los Alamos)